FDA rejects Scholar Rock's apitegromab application due to facility issues
Go back to FDA rejects Scholar Rock's apitegromab application due to facility issues| (NASDAQ: SRRK) | Delayed: 56.71 -1.23 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.94 | 52 Week High | $ | |||
| Open | $57.24 | 52 Week Low | $ | |||
| Day High | $58.49 | P/E | N/A | |||
| Day Low | $55.14 | EPS | $ | |||
| Volume | 829,110 | |||||
